Ambu has appointed Scott Heinzelman as president of its North America commercial region, effective immediately.

Abbott (NYSE: ABT) announced today that it received CE mark for its Esprit BTK everolimus-eluting resorbable scaffold system.

ProVerum announced today that it closed an $80 million Series B equity financing to support its benign prostatic hyperplasia ...

Otsuka Medical Devices announced that Japanese authorities approved the Recor Medical Paradise ultrasound renal denervation ...

The FDA issued a notice outlining a serious recall of the Boston Scientific (NYSE:BSX) carotid WallStent monorail ...

Terumo announced today that it entered into a definitive agreement to acquire OrganOx and its organ preservation technology.

Solventum (NYSE:SOLV) today announced that it commenced offers to purchase outstanding notes for up to $1.75 billion.

Restor3d announced today that it entered into a strategic investment partnership with global private market firm Partners ...

Boston Scientific announced today that it initiated a new trial to assess its Agent DCB compared to the standard of care.

Zeiss Medical Technology announced today that it received CE mark approval for its Cirrus PathFinder clinical support tool.

Method AI announced today that it raised $20 million in Series A funding to support its novel surgical ultrasound platform. The Boston-based company, co-founded by former Corindus COO Doug Teany, who ...

BrainsWay (Nasdaq:BWAY) announced today that it closed an initial strategic investment of $5 million in Neurolief.